T/CDAS 024-2025 Active Group standards

T/CDAS 024-2025 Environmental Management Guidelines for Pharmaceutical Companies

T/CDAS 024-2025 Environmental Management Guidelines for Pharmaceutical Companies

Publish Date: 2025-08-04 Implement Date: 2025-08-04 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CDAS 024-2025
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: X-ray, magnetic particle, fluorescence, and other nondestructive testing instruments
ICS Name: Integrated Environment and Environmental Protection
Publish Date: 2025-08-04
Implement Date: 2025-08-04

Scope

This document specifies the terms and definitions, general requirements, requirements for preventing and controlling exhaust gas pollution, requirements for preventing and controlling wastewater pollution, requirements for preventing and controlling solid waste pollution, other pollution prevention and control requirements, monitoring and control requirements, emergency management of environmental incidents, environmental management ledgers and file management, environmental education and training, and supervision and inspection requirements for the environmental management guidelines of pharmaceutical enterprises. This document applies to pharmaceutical enterprises and drug research and development institutions in conducting standardized environmental management. Other enterprises that generate pollution may refer to and implement it as appropriate. This document may be used as a reference by environmental regulatory authorities. 1 Scope This document specifies the terms and definitions, general requirements, requirements for preventing and controlling exhaust gas pollution, requirements for preventing and controlling wastewater pollution, requirements for preventing and controlling solid waste pollution, other pollution prevention and control requirements, monitoring and control requirements, emergency management of environmental incidents, environmental management ledgers and file management, environmental education and training, and supervision and inspection requirements for the environmental management guidelines of pharmaceutical enterprises. This document applies to pharmaceutical enterprises and drug research and development institutions in conducting standardized environmental management. Other enterprises that generate pollution may refer to and implement it as appropriate. This document may be used as a reference by environmental regulatory authorities. 2 Normative References The content of the following documents is an integral part of

Development Information

Related Standards

Contact Us